...
Example diagrams for MP (containing)
Stated template view:
Image Removed
| Gliffy Diagram |
|---|
| size | 800 |
|---|
| displayName | MP (only) |
|---|
| name | MP (only) |
|---|
| pagePin | 1 |
|---|
|
Figure 12: Medicinal Product (containing) stated template view
Example: single active ingredient product: stated view (including therapeutic role) followed by the inferred view that shows the grouper concept associated with the product:
...
Example diagrams for MP (only)
Stated template view:
Image Removed
| Gliffy Diagram |
|---|
| size | 800 |
|---|
| displayName | Medicinal Product Only |
|---|
| name | Medicinal Product Only |
|---|
| pagePin | 1 |
|---|
|
Figure 17: Medicinal Product (only) stated template view
Example: single active ingredient product: stated view followed by the inferred view that shows the proximal parent MP concept associated with the product:
...
| Semantic tag | (medicinal product) |
| Definition status | | Concept |
|---|
| t | 900000000000073002 |Sufficiently defined concept definition status| |
|---|
|
Exceptions |
Attribute | Scg expression |
|---|
1142139005 |Count of base of active ingredient| |
| Range Cardinality Notes - This attribute provides the number of base active ingredient substances present in the medicinal product
|
| Role Group | Attribute | Scg expression |
|---|
127489000 |Has active ingredient| |
| Range Range: | Scg expression |
|---|
| < 105590001|Substance| |
- descendants only, excluding concepts representing structural groupers, dispositions, or combined substances - Excluding concepts representing structural groupers, dispositions, or combined substances
Cardinality Notes - There is no technical limit on the number of
| Concept |
|---|
| ShowParts | term |
|---|
| t | 127489000 |Has active ingredient| |
|---|
|
attributes that may be added to a concept; a practical limit may be imposed at a later date - This attribute describes the set of active ingredient substances that the concept minimally contains. A set set of active ingredient substances may well have only one member
|
...
| Semantic tag | (medicinal product) |
| Definition status | | Concept |
|---|
| t | 900000000000073002 |Sufficiently defined concept definition status| |
|---|
|
Exceptions |
| Role Group | Attribute | Scg expression |
|---|
762949000 |Has precise active ingredient| |
| Range
| Scg expression |
|---|
< 105590001|Substance| |
- Excluding concepts representing structural groupers, dispositions, or combined substances
Cardinality Notes - This is the set of precise active ingredient substances that the medicinal product contains. A set of precise active ingredient substances may have only one member
|
Attribute | Scg expression |
|---|
1142139005 |Count of base of active ingredient| |
| Range Cardinality Notes - This attribute provides the number of base active ingredient substances present in the medicinal product
|
Attribute | Scg expression |
|---|
1142141006 |Count of base and modification pair| |
| Range Cardinality Notes - This attribute provides the number of base active ingredient substances present in the medicinal product
- This attribute should only be present and valued for multi-ingredient product concepts where two or more active ingredients are share the same base active ingredient (i.e. parent ingredient substance) and for single ingredient product concepts where the active substance is an ingredient in multi-ingredient products. As discussed above, and as described in the MRCM rules, the additional ingredient count attributes have to be applied iteratively
|
Attribute | Scg expression |
|---|
1142140007 |Count of active ingredient| |
| Range Cardinality Notes - This attribute provides the number of active ingredients present in the medicinal product
- This attribute should only be present and valued for multi-ingredient concepts where two or more active ingredients are share the same base active ingredient (i.e. parent ingredient substance) and where one is a further modification of the other (for example, a multi-ingredient product containing both dexamethasone phosphate and dexamethasone sodium phosphate, where the dexamethasone phosphate is a modification of dexamethasone (base) and dexamethasone sodium phosphate is a further modification of the dexamethasone phosphate), and for single ingredient product concepts where the active substance is an ingredient in multi-ingredient products. As discussed above, and as described in the MRCM rules, the additional ingredient count attributes have to be applied iteratively.
|
...